Lindy Biosciences: Funding, Investors & Team (Aug 2026)
Lindy Biosciences is a development-stage protein therapeutic formulations company. Our core technology produces spherical, dense, stable particles of a therapeutic protein. These protein particles are ideal for long-term storage, or for non-standard formulations such as suspension formulations (for high-concentration delivery of antibodies), encapsulation (for sustained/controlled release), or dry powder pulmonary delivery.
Lindy Biosciences has raised $3.3M across 1 funding round on record, the most recent an undisclosed round of $3.3M announced in Mar 2022.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Lindy Biosciences Company Profile and Key Stats
Latest funding round on record: Mar 2022.
Lindy Biosciences Funding Rounds
Lindy Biosciences Founders and Leadership Team
No contact details are on record for this team yet.
Lindy Biosciences Funding Compared to Other Biotechnology Startups
Lindy Biosciences' latest round of $3.3M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Lindy Biosciences in Biotechnology and Durham
Companies Similar to Lindy Biosciences
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Paterna BioSciences, Inc. is a pioneering biotechnology company dedicated to solving the significant…
Legendary Bio's solidarity is a determined spotlight on introducing another period of quality guideline.
Cataract surgery is the single most common procedure performed in the United States annually. Despite…
InSitu Biologics is a developer of a drug delivery platform designed to focus on development of new and…
Remedium Bio is a gene therapy company in the Boston area that is dedicated to developing cures for severe…
Lindy Biosciences Funding FAQs
What does Lindy Biosciences do?
Lindy Biosciences is a development-stage protein therapeutic formulations company. Our core technology produces spherical, dense, stable particles of a therapeutic protein. These protein particles are ideal for long-term storage, or for non-standard formulations such as suspension formulations (for high-concentration delivery of antibodies), encapsulation (for sustained/controlled release), or dry powder pulmonary delivery.
How much funding has Lindy Biosciences raised?
Lindy Biosciences has raised $3.3M across 1 round on record. The most recent is an undisclosed round of $3.3M announced in Mar 2022.
When did Lindy Biosciences last raise funding?
Lindy Biosciences' most recent funding round on record is an undisclosed round of $3.3M, announced in Mar 2022.
Who is the CEO of Lindy Biosciences?
Deborah Bitterfield is listed as CEO at Lindy Biosciences.
Where is Lindy Biosciences headquartered?
Lindy Biosciences is based in Durham, North Carolina, United States.
How many employees does Lindy Biosciences have?
Lindy Biosciences is in the 11-50 employee band.
How does Lindy Biosciences' funding compare to other Biotechnology startups?
Lindy Biosciences' latest round of $3.3M is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Lindy Biosciences Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Lindy Biosciences is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.